Brown Kimberly M, Geller David A
Department of Surgery, University of Texas Medical Branch, Galveston, TX, USA.
Liver Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
J Gastrointest Surg. 2016 May;20(5):1065-71. doi: 10.1007/s11605-016-3100-8. Epub 2016 Mar 8.
Laparoscopic liver resection is rapidly expanding with more than 9500 cases performed worldwide. While initial series reported non-anatomic resection of benign peripheral hepatic lesions, approximately 50-65 % of laparoscopic liver resections are now being done for malignant tumors, primarily hepatocellular carcinoma (HCC) or colorectal cancer liver metastases (mCRC).
We performed a literature review of published studies evaluating outcomes of major laparoscopic liver resection, defined as three or more Couinaud segments.
Initial fears of adverse oncologic outcomes or tumor seeding have not been demonstrated, and dozens of studies have reported comparable 5-year disease-free and overall survival between laparoscopic and open resection of HCC or mCRC in case-cohort and propensity score-matched analyses. Increased experience has led to laparoscopic anatomic liver resections including laparoscopic major hepatectomy. A steep learning curve of 45-60 cases is evident for laparoscopic hepatic resection.
Laparoscopic major hepatectomy is safe and effective in the treatment of benign and malignant liver tumors when performed in specialized centers with dedicated teams. Comparable to other complex laparoscopic surgeries, laparoscopic major hepatectomy has a learning curve of 45-60 cases.
腹腔镜肝切除术正在迅速发展,全球已完成超过9500例手术。虽然最初的系列报道是对良性周围性肝病变进行非解剖性切除,但目前约50%-65%的腹腔镜肝切除术是针对恶性肿瘤进行的,主要是肝细胞癌(HCC)或结直肠癌肝转移(mCRC)。
我们对已发表的评估主要腹腔镜肝切除术(定义为三个或更多Couinaud肝段)结果的研究进行了文献综述。
最初对不良肿瘤学结果或肿瘤种植的担忧尚未得到证实,并且几十项研究在病例队列和倾向评分匹配分析中报告了腹腔镜与开放切除HCC或mCRC之间5年无病生存率和总生存率相当。经验的增加导致了腹腔镜解剖性肝切除术,包括腹腔镜大肝切除术。腹腔镜肝切除术明显存在45-60例的陡峭学习曲线。
在配备专业团队的专业中心进行腹腔镜大肝切除术治疗良性和恶性肝肿瘤是安全有效的。与其他复杂的腹腔镜手术类似,腹腔镜大肝切除术有45-60例的学习曲线。